Directors & Officers Disclosures

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Hallenstein Glasson Holdings Limited (HLG)
Date this disclosure made:
6 November 2025
Date on which issuer listed or appointment made:
6 November 2025
Note: April Ward was re-designated as a Senior
Manager of HLG on 6 November 2025 after a
period during which she was not designated a
Senior Manager. Her position in the HLG group
did not change during this period.
Director or senior manager giving disclosure
Full name:
April Ward
Name of listed issuer:
Hallenstein Glasson Holdings Limited (HLG)
Name of related body corporate (if applicable):
N/A
Position held in listed issuer:
Glassons New Zealand Chief Executive Officer
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary Shares (NZX code: HLG)
Number held in class:
80,460
Nature of relevant interest:
Registered holder and beneficial owner
Current registered holder: April Ward
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
Class of underlying financial products:
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
6 November 2025
Name and title of authorised person:Cameron Alderton, Group Chief Financial Officer